Mallinckrodt has filed a patent for a therapeutic gas delivery system that includes a gas supply subsystem, a delivery system controller, and one or more displays. The displays are capable of showing graphical, illustrative, or numerical indicators of flow or system parameters. GlobalData’s report on Mallinckrodt gives a 360-degree view of the company including its patenting strategy. Buy the report here.

Smarter leaders trust GlobalData

Report-cover

Data Insights Mallinckrodt Plc - Company Profile

Buy the Report

Data Insights

The gold standard of business intelligence.

Find out more

According to GlobalData’s company profile on Mallinckrodt, was a key innovation area identified from patents. Mallinckrodt's grant share as of September 2023 was 55%. Grant share is based on the ratio of number of grants to total number of patents.

Therapeutic gas delivery system with display for parameters

Source: United States Patent and Trademark Office (USPTO). Credit: Mallinckrodt Plc

A recently filed patent (Publication Number: US20230270960A1) describes a therapeutic gas delivery system that includes various features to enhance its functionality and user-friendliness. The system comprises at least one gas supply subsystem, a therapeutic gas delivery system controller, and one or more displays. The displays are configured to show graphical, illustrative, or numerical indicators of flow parameters and system parameters. Additionally, the displays can also present visual alarms to alert users of any issues.

The patent also mentions that the therapeutic gas delivery system controller can produce audible alarms to further notify users of any problems. The displays are capable of showing bar graphs, charts, or numerical displays to represent the values of flow parameters and system parameters. Furthermore, the displays can present a graphic representation of the therapeutic gas delivery system, including indicators for the flow of therapeutic gas through the system.

The therapeutic gas delivery system is specifically designed for delivering nitric oxide gas. The displays can provide information about the concentration and flow rate of nitric oxide and breathing gas through the system. The system also includes an electrical power supply connection, an internal battery, and a power button with a power indicator to visually indicate the status of the power supply and battery charge.

Other features of the system include an alarm silence button with an alarm indicator to show the status of alarms, a global status indicator to display various global statuses of the system, and port indicators to visually indicate the delivery status of different outlets. The system can also monitor the status of compressed gas cylinders, including the percentage of available therapeutic gas and whether they are in low or high priority alarms.

The patent also describes the use of secondary delivery subsystems and breathing circuits in the therapeutic gas delivery system. The displays can show the delivery of therapeutic gas through these subsystems and circuits. Various types of breathing circuits are mentioned, such as conventional ventilator circuits, anesthesia circuits, and high flow nasal cannula oxygen therapy circuits.

Another notable feature of the system is the automatic switchover between compressed gas cylinders. When one cylinder is depleted, the system controller performs an automatic switchover to the second cylinder, ensuring continuous uninterrupted delivery of therapeutic gas to the patient. This switchover also provides time for replacing the depleted cylinder and verifying the concentration and expiration date of the replacement cylinder.

Overall, this patent describes a comprehensive therapeutic gas delivery system with advanced display capabilities, alarms, and automatic switchover functionality, aimed at improving the delivery of therapeutic gases to patients.

To know more about GlobalData’s detailed insights on Mallinckrodt, buy the report here.

Data Insights

From

The gold standard of business intelligence.

Blending expert knowledge with cutting-edge technology, GlobalData’s unrivalled proprietary data will enable you to decode what’s happening in your market. You can make better informed decisions and gain a future-proof advantage over your competitors.

GlobalData

GlobalData, the leading provider of industry intelligence, provided the underlying data, research, and analysis used to produce this article.

GlobalData Patent Analytics tracks bibliographic data, legal events data, point in time patent ownerships, and backward and forward citations from global patenting offices. Textual analysis and official patent classifications are used to group patents into key thematic areas and link them to specific companies